A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Food Effect of JZP047 in Healthy Participants
StatusRecruiting
PhasePhase 1
Started2026-02-03
View on ClinicalTrials.gov ↗
Record status
This record was last updated April 20, 2026 (before its estimated July 5, 2026 completion). Its status may not reflect the trial's current state.
Amendment history
2026-04-15
notable
Study Status, Contacts/Locations v1
Recruitment opened
2026-01-21
minor
Original filing
34 trials monitored
See 1 trial at risk
This is a Phase 1, double-blind, sponsor-unblinded, randomized, placebo-controlled study designed to characterize the safety, tolerability, and PK of JZP047 in healthy participants following single-ascending doses of study intervention. Additionally, the effect of food on PK following a single dose of JZP047 will be assessed through comparison of PK between the fed and fasted states.
| NCT Number |
NCT07377539 |
| Lead Sponsor |
Jazz Pharmaceuticals
Collaborators: Jazz Pharmaceuticals Ireland Limited |
| Conditions |
Healthy Participants |
| Enrollment |
86 participants |
| Start Date |
2026-02-03 |
| Primary Completion |
2026-07-05 (estimated) |
| Study Completion |
2026-07-05 (estimated) |
| Updated on ClinicalTrials.gov |
2026-04-20 |